SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
08-Jun-22 4:09 PM View: | Quince Therapeutics, Inc. (QNCX) | 06-Jun-22 | Payment of Exercise | 6,700 | $2.86 | $19,183.40 | (5%) 140.0K to 133.3K | |
08-Jun-22 4:09 PM View: | Quince Therapeutics, Inc. (QNCX) | 06-Jun-22 | Sale | 10,800 | $2.86 | $30,922.60 | (8%) 133.3K to 122.5K | |
04-Mar-22 5:57 PM View: | Quince Therapeutics, Inc. (QNCX) | 03-Mar-22 | Grant | 140,000 | -- | -- | 100% 0 to 140.0K | |
19-Feb-20 8:23 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Feb-20 | Payment of Exercise | 864 | $25.33 | $21,885.10 | (4%) 24.32K to 23.45K | (9%) |
03-Jan-20 6:46 PM View: | Revance Therapeutics, Inc. (RVNC) | 31-Dec-19 | Acquisition (other) | 382 | $10.82 | $4,133.24 | 2% 23.93K to 24.32K | 1% |
02-Jul-19 9:14 PM View: | Revance Therapeutics, Inc. (RVNC) | 28-Jun-19 | Acquisition (other) | 1,000 | $11.02 | $11,024.50 | 4% 22.93K to 23.93K | (< 1%) |
17-Jun-19 8:30 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Jun-19 | Payment of Exercise | 1,383 | $10.86 | $15,019.40 | (6%) 24.32K to 22.93K | (154%) |
25-Jan-19 8:54 PM View: | Revance Therapeutics, Inc. (RVNC) | 24-Jan-19 | Grant | 7,500 | -- | -- | 45% 16.82K to 24.32K | |
02-Jan-19 8:05 PM View: | Revance Therapeutics, Inc. (RVNC) | 31-Dec-18 | Acquisition (other) | 818 | $17.11 | $13,996.40 | 5% 16.0K to 16.82K | |
03-May-18 8:23 PM View: | Revance Therapeutics, Inc. (RVNC) | 01-May-18 | Grant | 16,000 | -- | -- | 100% 0 to 16.0K | |
01-Mar-18 7:12 PM View: | Cytokinetics Inc. (CYTK) | 28-Feb-18 | Payment of Exercise | 2,452 | $7.75 | $19,003.00 | (7%) 35.0K to 32.55K | (171%) |
01-Mar-18 7:12 PM View: | Cytokinetics Inc. (CYTK) | 27-Feb-18 | Grant | 20,000 | $0.00 | $20.00 | 133% 15.0K to 35.0K | |
18-Jan-18 8:10 PM View: | Cytokinetics Inc. (CYTK) | 16-Jan-18 | Option Exercise | 2,709 | $6.53 | $17,694.00 | 18% 15.0K to 17.71K | |
18-Jan-18 8:10 PM View: | Cytokinetics Inc. (CYTK) | 16-Jan-18 | Market Option Sale (Planned) | 2,709 | $9.00 | $24,381.00 | (15%) 17.71K to 15.0K | (134%) |
06-Nov-17 8:19 PM View: | Cytokinetics Inc. (CYTK) | 02-Nov-17 | Option Exercise | 1,355 | $6.53 | $8,850.35 | 8% 17.91K to 19.26K | |
06-Nov-17 8:19 PM View: | Cytokinetics Inc. (CYTK) | 02-Nov-17 | Market Option Sale (Planned) | 1,355 | $12.94 | $17,536.80 | (7%) 19.26K to 17.91K | (62%) |
06-Nov-17 8:19 PM View: | Cytokinetics Inc. (CYTK) | 02-Nov-17 | Market Sale (Planned) | 2,905 | $12.94 | $37,597.20 | (16%) 17.91K to 15.0K | (62%) |
10-Oct-17 7:20 PM View: | Cytokinetics Inc. (CYTK) | 06-Oct-17 | Option Exercise | 11,583 | $6.51 | $75,351.50 | 63% 18.37K to 29.95K | |
10-Oct-17 7:20 PM View: | Cytokinetics Inc. (CYTK) | 06-Oct-17 | Market Option Sale (Planned) | 11,583 | $15.49 | $179,410.00 | (39%) 29.95K to 18.37K | (36%) |
10-Oct-17 7:20 PM View: | Cytokinetics Inc. (CYTK) | 06-Oct-17 | Market Sale (Planned) | 1,598 | $15.49 | $24,751.60 | (9%) 18.37K to 16.77K | (36%) |
08-Sep-17 4:48 PM View: | Cytokinetics Inc. (CYTK) | 06-Sep-17 | Option Exercise | 10,231 | $6.50 | $66,521.20 | 56% 18.37K to 28.6K | |
08-Sep-17 4:48 PM View: | Cytokinetics Inc. (CYTK) | 06-Sep-17 | Market Option Sale (Planned) | 10,131 | $14.60 | $147,864.00 | (35%) 28.6K to 18.47K | (44%) |
08-Sep-17 4:48 PM View: | Cytokinetics Inc. (CYTK) | 06-Sep-17 | Market Sale (Planned) | 100 | $15.00 | $1,500.00 | (< 1%) 18.47K to 18.37K | (40%) |
10-Aug-17 7:56 PM View: | Cytokinetics Inc. (CYTK) | 08-Aug-17 | Option Exercise | 9,538 | $6.50 | $61,995.20 | 47% 20.18K to 29.72K | |
10-Aug-17 7:56 PM View: | Cytokinetics Inc. (CYTK) | 08-Aug-17 | Market Option Sale (Planned) | 9,538 | $12.47 | $118,903.00 | (32%) 29.72K to 20.18K | (69%) |
10-Aug-17 7:56 PM View: | Cytokinetics Inc. (CYTK) | 08-Aug-17 | Market Sale (Planned) | 1,810 | $12.47 | $22,563.90 | (9%) 20.18K to 18.37K | (69%) |
02-Mar-17 7:06 PM View: | Cytokinetics Inc. (CYTK) | 28-Feb-17 | Grant | 15,000 | $0.00 | $15.00 | 419% 3.58K to 18.58K |